Clinical Trial Update: Single Ascending Dose Study in Participants With LCA10 [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a single ascending dose study in Leber Congenital Amaurosis 10, a Phase 1/2 trial involving Editas Medicine; current status is unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leber Congenital Amaurosis 10

Snippet

Sponsor: Editas Medicine, Inc. | Conditions: Leber Congenital Amaurosis 10, Inherited Retinal Dystrophies | Phase 1, Phase 2 | Status: UNKNOWN